Science Group plc Completes 15,000 Share Buyback at 585p on AIM, Boosting Treasury Holdings

6 min read | July 21, 2026 07:00 AM BST | By Divya Sood

Science Group plc (AIM:SAG) announced the repurchase of 15,000 ordinary shares on 20 July 2026 as part of its ongoing share buyback programme. The shares were bought at a fixed price of 585 pence each via broker Panmure Liberum Limited and will be held in treasury. This transaction accounts for 0.04% of the company's voting rights, leaving 40,672,593 shares in issue excluding treasury shares.

Key Points

  • Science Group plc (AIM:SAG) acquired 15,000 ordinary shares on 20 July 2026 at 585 pence per share
  • Buyback executed through Panmure Liberum Limited, the company’s nomad and joint broker
  • Shares repurchased represent 0.04% of voting rights; total shares in issue now 40,672,593 excluding treasury holdings
  • Post-transaction, Science Group holds 5,513,281 shares in treasury
  • Investors should use the updated denominator of 40,672,593 for FCA Disclosure Guidance and Transparency Rules calculations

Share Repurchase Carried Out at Consistent 585 Pence Price

On 20 July 2026, Science Group plc completed the purchase of 15,000 of its 1 pence ordinary shares at a uniform price of 585 pence per share. The transaction was conducted as a single block trade through Panmure Liberum Limited, the company’s nominated adviser and joint broker, during afternoon trading on the AIM market. Execution occurred at 15:32:43 on the AIMX trading venue, reflecting a deliberate and consolidated approach rather than multiple smaller trades throughout the day.

The fixed price across all shares indicates a pre-arranged block purchase, minimizing execution risk and providing management certainty over capital deployment. The total consideration amounted to approximately A387,750 before transaction costs, which were not separately disclosed.

Treasury Shares Increase Following 0.04% Voting Rights Reduction

Following this buyback, Science Group’s treasury holdings rose to 5,513,281 shares reserved for future corporate use. The 15,000 shares repurchased represent a modest 0.04% of voting rights prior to the transaction, underscoring a measured execution of the broader buyback programme. Treasury shares carry no voting rights or dividends, effectively reducing circulating voting shares and potentially enhancing earnings per share for remaining shareholders.

This incremental buyback strategy allows Science Group to allocate capital prudently over time and adapt to market conditions. The announcement does not specify remaining buyback authorisation or a timeline for further purchases, leaving investors to monitor future disclosures for updates on treasury share accumulation.

Updated Share Capital and FCA Disclosure Thresholds

Post-transaction, Science Group confirmed 40,672,593 ordinary shares are in issue excluding treasury shares. This figure is crucial for shareholders as it serves as the denominator for calculating notification thresholds under the FCA’s Disclosure Guidance and Transparency Rules (DTR). Shareholders must use this updated figure when determining if they must disclose interests or changes in holdings.

With 40,672,593 shares in issue and 5,513,281 held in treasury, the total authorised ordinary share capital approximates 46.19 million shares. Treasury shares represent roughly 11.9% of total issued share capital, providing the board with significant flexibility for capital management, employee schemes, or strategic transactions. The announcement does not disclose the original authorisation limit or shares available for future issuance beyond treasury holdings.

Buyback Executed via Panmure Liberum Limited and Broker Roles

Panmure Liberum Limited, serving as Science Group’s nominated adviser and joint broker, executed the share repurchase through its trading desk. The company also retains Peel Hunt LLP as joint broker, a common dual-broker setup among AIM-listed firms to support liquidity and market-making.

Utilizing a regulated broker ensures compliance with market abuse regulations and investor confidence in the transaction’s governance. The disclosed schedule of purchases complies with Article 5(1)(b) of Regulation (EU) No 596/2014 (Market Abuse Regulation), detailing execution venue, timing, and price to ensure transparency. Contact details for both brokers and the company secretary are provided for further inquiries.

Overview of Science Group’s Business Model and Market Position

Science Group plc operates as a professional services and consulting firm within engineering, science, and technology sectors, serving both corporate and public clients. Its primary revenue stems from expert advisory, technical consulting, and project management across various industries. While financial metrics were not disclosed, the company’s AIM listing indicates compliance with regulatory and suitability standards.

AIM-listed companies often experience different liquidity and analyst coverage compared to main market firms. Share buybacks by AIM companies typically signal management’s confidence in strategy and valuation. The 585 pence share price reflects market valuation at the transaction date, though no comparison to prior trading levels or intrinsic value estimates was provided.

Capital Allocation and Treasury Share Strategy

Science Group’s share buyback reflects a capital allocation decision favoring repurchasing shares over alternatives such as acquisitions, organic growth investments, or dividend increases. Holding shares in treasury preserves flexibility, as these shares can be reissued, cancelled, or used for employee schemes without new shareholder approval.

The 5.5 million treasury shares represent a significant capital reserve, enabling rapid deployment for strategic opportunities like acquisitions, geographic expansion, or service consolidation. The announcement does not specify management’s policies or intended uses for treasury shares.

Compliance with Market Abuse Regulation and Transparency Standards

The company disclosed the buyback in full compliance with Article 5 of Regulation (EU) No 596/2014, reporting all relevant transaction details to regulated information services. This transparency supports market surveillance and helps prevent misconduct or manipulation.

Released via the Regulatory News Service (RNS) on 21 July 2026, the announcement ensures simultaneous market access to information, meeting timely disclosure requirements. Contact details for Panmure Liberum Limited and Peel Hunt LLP provide avenues for investor queries.

Impact on Earnings Per Share and Valuation Metrics

The reduction in shares outstanding to 40,672,593 will mechanically increase Science Group’s earnings per share, assuming stable profitability, by spreading earnings over fewer shares. This financial engineering benefit enhances shareholder value independent of operational performance.

Market participants distinguish accretion from buybacks versus organic growth. Sustained repurchases can significantly boost shareholder returns, especially when shares are bought below intrinsic value. The announcement does not disclose current price-to-earnings ratios, earnings guidance, or management’s valuation views.

Ongoing Disclosure and Shareholder Notification Considerations

Shareholders should note the updated denominator of 40,672,593 for calculating FCA disclosure thresholds. Those approaching 3%, 5%, 10%, or other levels must use this figure to determine notification obligations. Science Group is expected to continue updating the market on buyback activity via RNS announcements, allowing investors to track cumulative effects on share capital and treasury holdings.

Future buyback frequency, pricing, or pauses may signal shifts in management’s confidence or capital allocation priorities in response to market or operational changes.

This article is for informational purposes only and does not constitute investment advice. The content is based solely on Science Group plc’s regulatory announcement and should not be the sole basis for investment decisions. Readers should perform their own due diligence, review full regulatory disclosures, and consult qualified financial advisers before investing in Science Group plc or any other securities. Share prices and market conditions are subject to change, and past performance is not indicative of future results.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.